NASDAQ:MLEC Moolec Science (MLEC) Stock Price, News & Analysis $1.72 +0.01 (+0.35%) As of 11:31 AM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsNews and TrendsOwnershipSEC Filings About Moolec Science Stock (NASDAQ:MLEC) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Moolec Science alerts:Sign Up Key Stats Today's Range$1.69▼$1.7750-Day Range$1.71▼$8.5752-Week Range$1.64▼$23.22Volume5,704 shsAverage Volume516,301 shsMarket Capitalization$1.25 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Moolec Science Ltd. is a food-technology and biotechnology company developing alternative sources of animal proteins through molecular farming. The company uses genetically engineered plants, including soybeans and safflower, as biological production platforms designed to produce specific proteins that can be used in food and other applications. Its research and development programs have included “Piggy Sooy,” a soybean engineered to produce pork protein, as well as safflower-based production of animal proteins such as chymosin, an enzyme used in cheese manufacturing. Moolec’s approach is intended to support the production of animal-derived ingredients with potentially lower resource requirements than conventional livestock-based methods. Moolec was founded in 2020 and has developed activities connected with biotechnology and agricultural research in the United States and South America. The company is led by Chief Executive Officer Gastón Paladini, who is associated with the Paladini food group and has experience in the food industry. Moolec Science is listed on the Nasdaq under the symbol MLEC.AI Generated. May Contain Errors. Read More Moolec Science Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks18th Percentile Overall ScoreMLEC MarketRank™: 0.91244239631 of 5 starsMoolec Science scored higher than 18% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Moolec Science. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Moolec Science is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Moolec Science is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.48% of the float of Moolec Science has been sold short.Short Interest Ratio / Days to CoverMoolec Science has a short interest ratio ("days to cover") of 0.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Moolec Science has recently decreased by 68.37%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldMoolec Science does not currently pay a dividend.Dividend GrowthMoolec Science does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.47 News SentimentMoolec Science has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Moolec Science this week, compared to 2 articles on an average week. Company Ownership0.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Moolec Science insiders have not sold or bought any company stock.Percentage Held by Insiders19.90% of the stock of Moolec Science is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions0.07% of the stock of Moolec Science is held by institutions.Read more about Moolec Science's insider trading history. Receive MLEC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Moolec Science and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MLEC Stock News HeadlinesMoolec Science Calls October 20 Shareholder Vote on Voluntary Winding UpOctober 7, 2026 | tipranks.comMoolec Science Faces Cayman Winding Up Petition Over Disputed Legal FeesJuly 14, 2026 | tipranks.comFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.October 14 at 1:00 AM | Weiss Ratings (Ad)MLEC Share News TodayJune 15, 2026 | uk.investing.comMoolec Science Regains Nasdaq Compliance but Faces Year-Long MonitoringJune 2, 2026 | tipranks.comMoolec Science Shareholders Approve 2025 Accounts and Board Slate at May 13 AGMMay 14, 2026 | tipranks.comMoolec Science Swings to Profit on Subsidiary Deconsolidation in Latest Interim ResultsMay 14, 2026 | tipranks.comMoolec Science Regains Nasdaq Compliance After Strengthening Equity BaseMay 13, 2026 | tipranks.comSee More Headlines MLEC Stock Analysis - Frequently Asked Questions How have MLEC shares performed this year? Moolec Science's stock was trading at $3.8190 on January 1st, 2026. Since then, MLEC shares have decreased by 54.4% and is now trading at $1.74. How were Moolec Science's earnings last quarter? Moolec Science SA (NASDAQ:MLEC) posted its quarterly earnings results on Wednesday, April, 16th. The company reported ($9.00) earnings per share for the quarter, meeting analysts' consensus estimates of ($9.00). The firm had revenue of $2.64 million for the quarter, compared to the consensus estimate of $2.01 million. When did Moolec Science's stock split? Moolec Science's stock reverse split on the morning of Monday, January 5th 2026.The 1-15 reverse split was announced on Wednesday, December 31st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, January 2nd 2026. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split. How do I buy shares of Moolec Science? Shares of MLEC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings4/16/2025Today10/14/2026Fiscal Year End6/30/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2w+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 For the last 2 weeks, MLEC's financial health has been in the Red zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Staples Industry Food Products Sub-IndustryAgricultural Products & Services Current SymbolNASDAQ:MLEC CIK1937737 Webmoolecscience.com Phone+35226496565FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$333.61 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($309.64) per share Price / Book-0.01Miscellaneous Outstanding Shares730,000Free Float582,000Market Cap$1.35 million OptionableNot Optionable Beta0.33 10 Stocks Powering The Next AI Boom The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation. Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.Get This Free Report This page (NASDAQ:MLEC) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredWall Street legend reveals his top AI stock before Oct. 20Marc Chaikin, the 60-year Wall Street veteran behind the Power Gauge rating system, has flagged a new AI stock...Chaikin Analytics | SponsoredThe Iran War Isn’t Chaos. It’s Strategy.Two thousand missiles struck Iran. Three days later, Dylan Jovine sat in two private meetings with U.S. Congre...Behind the Markets | SponsoredHow one AI fund pays investors every ThursdayOne small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling ...Investors Alley | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Moolec Science SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Moolec Science With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.